Abstract
The aging population is impacting subspecialty areas outside of geriatrics. Rheumatic diseases increase with age. Therapy for these diseases can add to polypharmacy and negatively impact other comorbidities. This is a retrospective chart review of all patients attending a rheumatology subspeciality clinic over 1 year. Referrals were prescreened and excluded probable degenerative axial and peripheral disease and chronic pain syndromes. Data were collected on demographics, diagnoses, and medications. Two hundred ninety-five new patients were seen. Seventy-eight (26%) were seniors (age, >65 years) with a mean age of 73 years (65–90). Comparing the >65 to <65 age groups, the prevalence of inflammatory arthritides (rheumatoid arthritis (RA), psoriatic arthritis, palindromic rheumatism) was comparable: 48% vs 53%; however, osteoarthritis and polymyalgia rheumatica were twice as common in the older group. Comorbidities in the >65 age group included hypertension (31%), osteoporosis (27%), diabetes (15%), hypothyroidism (11%), and coronary artery disease (9%). Only one patient had documented dementia. There were no cases of uncontrolled hypertension identified, and all patients were receiving a mixture of anti-hypertensives. Eighty-one percent of osteoporosis patients were on antiresorptives, but only 40% of prednisone users were taking bisphosphonates. For RA, treatment was somewhat comparable between the groups, with all but two patients receiving disease-modifying antirheumatic drugs. Eleven percent were on biologics. Seniors comprise a significant number of referrals. Pharmacotherapy differs in seniors, with more use of prednisone and a probable contribution of polypharmacy. This study highlights the need for reciprocal knowledge by both geriatricians and rheumatologists to optimize the management of these complex patients.
Similar content being viewed by others
References
Majithia V, Peel C, Geraci S (2009) Rheumatoid arthritis in elderly patients. Geriatrics 64:22–28
Kievit W, van Hulst L, van Riel P, Fraenkel L (2010) Factors that influence rheumatologists' decisions to escalate care in RA: results from a choice based conjoint analysis. Arthritis Rheum 62:842–847
Radovits B, Fransen J, Eijsbouts A, van Riel P, Laan R (2009) Missed opportunities in the treatment of elderly patients with RA. Rheumatology 48:906–910
Harrison M, Kim C, Silverberg M, Paget S (2005) Does age bias the aggressive treatment of elderly patients with RA? J Rheumatol 32:1243–1248
Lacaille D, Anis A, Guh D, Esdaile J (2005) Gaps in care for RA: a population study. Arthritis Rheum 53:241–248
Schmajuk G, Schneeweis S, Katz J, Weinblatt M, Setoguchi S, Avorn J, Levin R, Solomon D (2007) Treatment of older adult patients diagnosed with RA: improved but not optimal. Arthritis Rheum 57:928–934
Shipton D, Glazier R, Guan J, Badley E (2004) Effects of use of specialty services on disease modifying antirheumatic drug use in the treatment of RA in an insured elderly population. Med Care 42:907–913
Tutuncu Z, Reed G, Kremer J, Kavanaugh A (2006) Do patients with older onset RA receive less aggressive treatment? Ann Rheum Dis 65:1226–1229
Fraenkel L, Rabidou N, Dhar R (2006) Are rheumatologists treatment decisions influenced by patients age? Rheumatology 45:1555–1557
De Coster C, Fitzgerald A, Cepoiu M (2008) Priority setting tools for rheumatology disease referrals: a review of the literature. Clin Rheum 27:1411–1416
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Juby, A., Davis, P. An evaluation of the impact of seniors on a rheumatology referral clinic: demographics and pharmacotherapy. Clin Rheumatol 30, 1507–1509 (2011). https://doi.org/10.1007/s10067-011-1845-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1845-8